Concepedia
Statistics
Publications
17
Citations
1.5K
H-Index
15
Active since
2013
Affiliations
Erasmus MC(Current)
University Health Network
Toronto General Hospital
University of Toronto
Ankara University
Heng Chi is an author at Erasmus MC specializing in viral hepatitis, liver disease, and hepatitis b therapy.
Publications per year
2013–2021
PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy
George Papatheodoridis, George Ν. Dalekos, Vana Sypsa et al. · Journal of Hepatology · 2015 · 541 citations
Medicine, Oncology, Hepatology +13
The risk of hepatocellular carcinoma decreases after the first 5 years of entecavir or tenofovir in Caucasians with chronic hepatitis B
George Papatheodoridis, Ramazan Idılman, George Ν. Dalekos et al. · Hepatology · 2017 · 292 citations
Medicine, Oncology, Pharmacotherapy +15
Eight-year survival in chronic hepatitis B patients under long-term entecavir or tenofovir therapy is similar to the general population
George Papatheodoridis, Vana Sypsa, George Ν. Dalekos et al. · Journal of Hepatology · 2018 · 109 citations
Medicine, Internal Medicine, Pharmacotherapy +12
Multiple biopsy passes and the risk of complications of percutaneous liver biopsy
Heng Chi, Bettina E. Hansen, Wing Yin Tang et al. · European Journal of Gastroenterology & Hepatology · 2016 · 101 citations
Medicine, Pathology, Surgery +14
Hepatocellular carcinoma prediction beyond year 5 of oral therapy in a large cohort of Caucasian patients with chronic hepatitis B
George Papatheodoridis, Vana Sypsa, George Ν. Dalekos et al. · Journal of Hepatology · 2020 · 100 citations · Full text
Medicine, Internal Medicine, Oncology +12
1–5 of 17